Outpatient Management of COVID-19: Rapid Evidence Review
- PMID: 33064422
Outpatient Management of COVID-19: Rapid Evidence Review
Abstract
Common presenting symptoms of coronavirus disease 2019 include fever, dry cough, shortness of breath, and fatigue. However, patients may have a wide range of symptoms representing a spectrum of mild to severe illness. Symptoms in children tend to be milder and may include fever, cough, and feeding difficulty. The incubation period is two to 14 days, although symptoms typically appear within five days of exposure. Multiple testing modalities exist, but infection should be confirmed by polymerase chain reaction testing using a nasopharyngeal swab. There are no evidence- based treatments appropriate for use in the outpatient setting; management is supportive and should include education about isolation. In hospitalized patients, remdesivir should be considered to reduce time to recovery, and low-dose dexamethasone should be considered in patients who require supplemental oxygen. Overall, 85% of patients have mild illness, whereas 14% have severe disease requiring hospitalization, including 5% who require admission to an intensive care unit. Predictors of severe disease include increasing age, comorbidities, lymphopenia, neutrophilia, leukocytosis, low oxygen saturation, and increased levels of C-reactive protein, d-dimer, transaminases, and lactate dehydrogenase.
Similar articles
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19.Front Med. 2020 Oct;14(5):664-673. doi: 10.1007/s11684-020-0810-9. Epub 2020 Aug 6. Front Med. 2020. PMID: 32761491 Free PMC article.
-
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839. JAMA. 2020. PMID: 32648899 Review.
-
The COVID-19 pandemic.J Pak Med Assoc. 2020 May;70(Suppl 3)(5):S4-S6. doi: 10.5455/JPMA.02. J Pak Med Assoc. 2020. PMID: 32515365 No abstract available.
-
COVID-19 in Children: Clinical Approach and Management.Indian J Pediatr. 2020 Jun;87(6):433-442. doi: 10.1007/s12098-020-03292-1. Epub 2020 Apr 27. Indian J Pediatr. 2020. PMID: 32338347 Free PMC article. Review.
Cited by
-
Association between mortality risk levels and AIFELL triage scores for suspected COVID-19 patients.J Educ Health Promot. 2024 Jan 22;12:454. doi: 10.4103/jehp.jehp_604_23. eCollection 2023. J Educ Health Promot. 2024. PMID: 38464647 Free PMC article.
-
Consequences of COVID-19 and Its Variants: Understanding the Physical, Oral, and Psychological Impact.Int J Environ Res Public Health. 2023 Feb 10;20(4):3099. doi: 10.3390/ijerph20043099. Int J Environ Res Public Health. 2023. PMID: 36833792 Free PMC article.
-
The AIFELL Score as a Predictor of Coronavirus Disease 2019 (COVID-19) Severity and Progression in Hospitalized Patients.Diagnostics (Basel). 2022 Feb 27;12(3):604. doi: 10.3390/diagnostics12030604. Diagnostics (Basel). 2022. PMID: 35328157 Free PMC article.
-
SARS-CoV-2 Immunization Orchestrates the Amplification of IFNγ-Producing T Cell and NK Cell Persistence.Front Immunol. 2022 Feb 14;13:798813. doi: 10.3389/fimmu.2022.798813. eCollection 2022. Front Immunol. 2022. PMID: 35237261 Free PMC article.
-
Effectiveness of Telephone Monitoring in Primary Care to Detect Pneumonia and Associated Risk Factors in Patients with SARS-CoV-2.Healthcare (Basel). 2021 Nov 13;9(11):1548. doi: 10.3390/healthcare9111548. Healthcare (Basel). 2021. PMID: 34828594 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials